Parameter | Frequency (%) or Mean ± SD [Range] |
---|---|
Male (%) | 18 (67Â %) |
Age (years) | 76.4 ± 7.3 [60–87] |
Education > Year 12 | 9 (33 %) |
Living with a partner | 22 (81Â %) |
Retired | 23 (85Â %) |
Smoker, current or former | 16 (59Â %) |
Body mass index (kg/m2) | 29.8 ± 5.1 [21.5–42.4] |
Serum creatinine (μmol/L) | 336.4 ± 178.2 [121–863] |
eGFR (mL/min/1.73 m2) | 17.0 ± 8.4 [5–36] |
CKD | |
 Stage 3b | 3 (11 %) |
 Stage 4 | 10 (37 %) |
 Stage 5 (non-dialysed) | 7 (26 %) |
 Stage 5 (haemodialysis) | 7 (26 %) |
Depression score (PHQ-9) | 3.5 ± 3.5 [0–14] |
Anxiety score (BAI) | 7.2 ± 6.4 [0–25] |
Cognitive functioning (in KDQOL-SF 1.3) | 86.2 ± 15.5 [46.7–100] |
≥3 comorbidities | 14 (52 %) |
Diabetes mellitus | 7 (26Â %) |
Hypertension | 21 (78Â %) |
Atherosclerotic heart disease | 9 (33Â %) |
Congestive heart failure | 9 (33Â %) |
Peripheral vascular disease | 7 (26Â %) |
Prescribed antidepressants | 3 (11Â %) |
Prescribed ACE inhibitors | 8 (30Â %) |
Prescribed Angiotensin II Receptor Blockers | 8 (30Â %) |
Prescribed statins | 18 (67Â %) |
Prescribed antibiotics | 2 (7Â %) |